Şule Apraş Bilgen

839 total citations
72 papers, 519 citations indexed

About

Şule Apraş Bilgen is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Şule Apraş Bilgen has authored 72 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Rheumatology, 15 papers in Pulmonary and Respiratory Medicine and 15 papers in Hematology. Recurrent topics in Şule Apraş Bilgen's work include Rheumatoid Arthritis Research and Therapies (19 papers), Spondyloarthritis Studies and Treatments (18 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). Şule Apraş Bilgen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (19 papers), Spondyloarthritis Studies and Treatments (18 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). Şule Apraş Bilgen collaborates with scholars based in Türkiye, United States and Cyprus. Şule Apraş Bilgen's co-authors include Ömer Karadağ, İhsan Ertenli, Sedat Kiraz, Umut Kalyoncu, Levent Kılıç, Ali Akdoğan, Abdülsamet Erden, Meral Çalgünerı, Berkan Armağan and İsmail Doğan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Medicine.

In The Last Decade

Şule Apraş Bilgen

63 papers receiving 499 citations

Peers

Şule Apraş Bilgen
Şule Apraş Bilgen
Citations per year, relative to Şule Apraş Bilgen Şule Apraş Bilgen (= 1×) peers Berkan Armağan

Countries citing papers authored by Şule Apraş Bilgen

Since Specialization
Citations

This map shows the geographic impact of Şule Apraş Bilgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şule Apraş Bilgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şule Apraş Bilgen more than expected).

Fields of papers citing papers by Şule Apraş Bilgen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şule Apraş Bilgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şule Apraş Bilgen. The network helps show where Şule Apraş Bilgen may publish in the future.

Co-authorship network of co-authors of Şule Apraş Bilgen

This figure shows the co-authorship network connecting the top 25 collaborators of Şule Apraş Bilgen. A scholar is included among the top collaborators of Şule Apraş Bilgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şule Apraş Bilgen. Şule Apraş Bilgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bılgın, Emre, Yahya Büyükaşık, Ömer Dızdar, et al.. (2023). Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry. Rheumatology and Therapy. 10(4). 969–981. 1 indexed citations
2.
Kılıç, Levent, Ertuğrul Çağrı Bölek, G. K. Yardimci, et al.. (2023). Fertility, early menopause and pregnancy outcomes of patients with Takayasu’s arteritis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 283. 1–5.
3.
Armağan, Berkan, Levent Kılıç, G. K. Yardimci, et al.. (2022). Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis. Rheumatology International. 43(1). 147–156. 7 indexed citations
4.
Bılgın, Emre, Ertuğrul Çağrı Bölek, Levent Kılıç, et al.. (2022). Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results. Clinical Rheumatology. 41(5). 1439–1446. 1 indexed citations
5.
Armağan, Berkan, Levent Kılıç, Şule Apraş Bilgen, et al.. (2021). Evaluation of Intravenous Immunoglobulin G treatment in Outpatients Rheumatology Practice. 1–8.
6.
Bılgın, Emre, Ertuğrul Çağrı Bölek, Serdar Özer, et al.. (2021). The clinical features and treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in Turkey: one or two distinct diseases?. Internal and Emergency Medicine. 17(3). 743–751. 7 indexed citations
7.
Ulaşlı, Sevinç Sarınç, et al.. (2021). Pulmonary manifestations of antiphospholipid syndrome: a retrospective analysis of 67 patients. Journal of Thrombosis and Thrombolysis. 52(2). 640–645. 2 indexed citations
8.
Doğan, İsmail, Umut Kalyoncu, Levent Kılıç, et al.. (2020). Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid. TURKISH JOURNAL OF MEDICAL SCIENCES. 50(1). 219–224. 6 indexed citations
9.
Bılgın, Emre, Ertuğrul Çağrı Bölek, G. K. Yardimci, et al.. (2020). Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(1). 297–308. 11 indexed citations
10.
Kılıç, Levent, Ömer Karadağ, Berkan Armağan, et al.. (2019). Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: real-life experience. TURKISH JOURNAL OF MEDICAL SCIENCES. 50(1). 31–36. 6 indexed citations
11.
Kalyoncu, Umut, Sedat Kiraz, Şule Apraş Bilgen, et al.. (2019). Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry. Clinical Rheumatology. 38(4). 1187–1192. 8 indexed citations
12.
Bılgın, Emre, Mutlu Hayran, Abdülsamet Erden, et al.. (2019). Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study. Clinical Rheumatology. 38(6). 1699–1706. 24 indexed citations
13.
Karadağ, Ömer, et al.. (2017). Therapeutic plasma exchange for refractory SLE: A comparison of outcomes between different sub-phenotypes. European Journal of Rheumatology. 5(1). 32–36. 11 indexed citations
14.
Karadağ, Ömer, Şule Apraş Bilgen, Berkan Armağan, et al.. (2017). P1_145 Two-year Results of a Prospective Vasculitis Cohort from Eastern Mediterranean: Demographic Characteristics and Distribution of the Vasculitides Frequencies. Lara D. Veeken. 56(suppl_3). iii88–iii95. 3 indexed citations
15.
Bilgen, Şule Apraş, Ali Akdoğan, Ömer Karadağ, et al.. (2014). Serum lipid changes and insulin resistance in familial Mediterranean fever. European Journal of Rheumatology. 1(4). 140–143. 7 indexed citations
16.
Akdoğan, Ali, Levent Kılıç, İsmail Doğan, et al.. (2014). Effect of capillaroscopic patterns on the pulse oximetry measurements in systemic sclerosis patients. Microvascular Research. 98. 183–186. 5 indexed citations
17.
Karadağ, Ömer, Umut Kalyoncu, Ali Akdoğan, et al.. (2011). Sonographic assessment of carpal tunnel syndrome in rheumatoid arthritis: prevalence and correlation with disease activity. Rheumatology International. 32(8). 2313–2319. 29 indexed citations
18.
Bilgen, Şule Apraş, Levent Kılıç, Ali Akdoğan, et al.. (2011). Effects of Anti-Tumor Necrosis Factor Agents for Familial Mediterranean Fever Patients With Chronic Arthritis and/or Sacroiliitis Who Were Resistant to Colchicine Treatment. JCR Journal of Clinical Rheumatology. 17(7). 358–362. 56 indexed citations
19.
Kalyoncu, Umut, Özlem Yönem, Meral Çalgünerı, et al.. (2008). Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders. Rheumatology International. 29(7). 777–780. 9 indexed citations
20.
Karadağ, Ömer, Meral Çalgünerı, Enver Atalar, et al.. (2006). Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients. Clinical Rheumatology. 26(5). 695–699. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026